ALLOAllogene Therapeutics, Inc.
2.090USD-6.28%Mkt Cap: 722.08M $P/E: —3d ago
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipe…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap722.08M $
Enterprise Value471.94M $
Revenue (TTM)4.64M $
Gross Profit-117.88M $
Net Income (TTM)-190.89M $
Revenue/Share0.0180 USD
Last Price2.090 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.99
PEG—
EV/EBITDA-2.80
EV/Revenue101.71
P/S156.36
P/B1.66
EPS (TTM)-0.62
EPS (Forward)-0.70
52W Range
1.03031% of range4.460
52W High4.460 USD
52W Low1.030 USD
Profitability
Gross Margin0.00%
Oper. Margin-1011.21%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-65.25%
ROA-45.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-149.25M $
CapEx (TTM)386.00K $
FCF Margin-1367.71%
FCF Yield-8.79%
Net Debt-253.59M $
Net Debt/EBITDA1.50
Balance Sheet
Debt/Equity0.28
Current Ratio10.72
Quick Ratio10.55
Book Value/Sh1.263 USD
Cash/Share0.9630 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.000 USD
Upside (mean)+330.6%
Target Range4.000 USD – 14.00 USD
$4.000+330.6% to mean$14.00
# Analysts9
Ownership
Shares Out.345.49M
Float267.31M
Insiders11.03%
Institutions87.30%
Short Interest
Short Ratio7.3d
Short % Float19.48%
Short % Out.17.60%
Shares Short60.75M
Short (prev mo.)63.39M
Technical
SMA 501.970 (+6.1%)
SMA 2001.919 (+8.9%)
Beta0.47
S&P 52W Chg18.16%
Avg Vol (30d)5.94M
Avg Vol (10d)4.99M
Technical Indicators
RSI (14)55.1
MACD0.0511
MACD Signal0.0252
MACD Hist.+0.0259
BB Upper2.248 USD
BB Middle1.951 USD
BB Lower1.654 USD
BB Width30.49%
ATR (14)0.1279 USD
Vol Ratio (20d)0.72x